ImageneBio, Inc.
IMA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001835579
In the last 90 days, ImageneBio, Inc. insiders filed 0 open-market purchases and 1 sale; 35 institutions reported holding it in 13F filings for Q2 2026, worth $36.8M in total; no superinvestor holds it.
Q1 2022 vs. Q4 2021
How the institutions holding ImageneBio, Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 49 | 48 | −1 |
| Shares | 27.4M | 27.5M | +99.9K (+0.4%) |
| Value | $343.6M | $167.8M | −$175.8M (−51.2%) |
New holders (9)
Institutions that held ImageneBio, Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Point72 Asset Management, L.P. | 348,696 | $2.13M | 0.01% |
| Barclays PLC | 205,594 | $1.25M | 0.00% |
| Voya Investment Management LLC | 11,117 | $68.0K | 0.00% |
| Nisa Investment Advisors, LLC | 8,000 | $49.0K | 0.00% |
| Cubist Systematic Strategies, LLC | 7,866 | $48.0K | 0.00% |
| Amalgamated Bank | 3,451 | $21.0K | 0.00% |
| Amalgamated Financial Corp. | 3,451 | $21.0K | 0.00% |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 2,472 | $15.0K | 0.00% |
| Point72 Hong Kong Ltd | 594 | $4.00K | 0.00% |
Sold out (10)
Institutions that held ImageneBio, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Ra Capital Management, L.P. | 750,000 | $9.40M |
| Victory Capital Management Inc | 112,330 | $1.41M |
| Millennium Management LLC | 17,333 | $217.0K |
| Susquehanna International Group, LLP | 14,567 | $183.0K |
| MetLife Investment Management | 11,742 | $147.2K |
| ProShare Advisors LLC | 11,111 | $138.0K |
| SG Americas Securities, LLC | 9,353 | $117.0K |
| Metropolitan Life Insurance Co | 8,698 | $109.1K |
| STRS Ohio | 2,100 | $26.0K |
| Captrust Financial Advisors | 113 | $1.00K |